Last reviewed · How we verify
NCT05819502: HIT-PRF
"Profile HIT" (Holistic Individualized Treatment)
NA trial testing Restylane line of injectables in Aesthetic in 18 participants. Completed in 24 March 2024.
24 February 2024
Quick facts
| Lead sponsor | Erevna Innovations Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 18 |
| Start date | 20 March 2023 |
| Primary completion | 24 February 2024 |
| Estimated completion | 24 March 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Restylane line of injectables — full drug profile →
Conditions studied
- Aesthetic — all drugs for Aesthetic →
Sponsor
Erevna Innovations Inc. — full company profile →
Who can join
18 and older, any sex, with Aesthetic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The "Holistic Individualized Treatment" (HIT) approach is used to identify treatment priorities, focus areas, and appropriate products for soft tissue filler treatments. The "Profile HIT" considers the balance between the midface, nose, lips, and chin to improve a patient's appearance. This trial will assess the effectiveness of the Profile HIT algorithm in treating patients with different profile issues (e.g. nasal deformities, volume loss, chin retrusion).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05819502
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aesthetic
Currently open trials in the same condition.
- NCT07383766 — Aesthetic Improvement of Facial Rhytids Using Injectables · Phase 4 · recruiting
- NCT07368686 — Topical Multivitamin Serum for Skin Heath · Phase 4 · recruiting
- NCT07210190 — Microneedling for Skin Heath · Phase 4 · recruiting
- NCT07079397 — Hyaluronic Acid Filler Migration · NA · recruiting
- NCT07202117 — PLLA and CaHA-R for Aesthetic Rejuvenation · Phase 4 · recruiting
Other Erevna Innovations Inc. trials
Trials by the same sponsor.
- NCT07383766 — Aesthetic Improvement of Facial Rhytids Using Injectables · Phase 4 · recruiting
- NCT07368686 — Topical Multivitamin Serum for Skin Heath · Phase 4 · recruiting
- NCT07210190 — Microneedling for Skin Heath · Phase 4 · recruiting
- NCT07079397 — Hyaluronic Acid Filler Migration · NA · recruiting
- NCT07202117 — PLLA and CaHA-R for Aesthetic Rejuvenation · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05819502 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Erevna Innovations Inc.
- Last refreshed: 4 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05819502.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing